Conivaptan
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide
Molecular Identity
Conivaptan
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide
PubChem CID: 151171
Conivaptan is the amide resulting from the formal condensation of 4-[(biphenyl-2-ylcarbonyl)amino]benzoic acid with the benzazepine nitrogen of 2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine. It is an antagonist for two of the three types of arginine vasopressin (AVP) receptors, V1a and V2. It is used as its hydrochloride salt for the treatment of hyponatraemia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH). It has a role as an aquaretic and a vasopressin receptor antagonist.
2D Structure
Properties
C32H26N4O2
Molecular Formula
498.60
Molecular Weight
g/mol
498.2056
Exact Mass
Da
5.7
XLogP
Above Lipinski threshold
78.1
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
3
H-Bond Acceptors
820
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Conivaptan210101-16-9YM087YM-087YM 0870NJ98Y462X4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilideCHEBI:681850DTXSID80175220[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-(1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-4''-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilideconivaptanumN-(4-((4-methyl-3,5,9-triazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),2(6),3,11,13-pentaen-9-yl)carbonyl)phenyl)-2-phenylbenzamideN-(4-(2-methyl4,5-dihydro-3H-imidazo(5,4-d)(1)benzazepine-6-carbonyl)phenyl)-2-phenylbenzamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Conivaptan
Loading drug network...